Form 4: HealthStream Director Deborah Taylor Tate Reports Stock Transaction
SEC Form 4 Filing
Director Deborah Taylor Tate reports the vesting of restricted share units into common stock of HealthStream Inc.
Summary
- On March 28, 2025, Deborah Taylor Tate, a director of HealthStream Inc. (HSTM), reported a transaction involving the vesting of restricted share units (RSUs).
- The transaction resulted in the acquisition of 1,149 shares of common stock at a price of $0 per share.
- Following the transaction, Ms. Tate directly owns 22,575 shares of HealthStream Inc.
- The RSUs vest annually beginning March 23, 2023, in three equal installments, contingent upon continued service.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reports a routine transaction related to executive compensation.
Positives
- The vesting of RSUs indicates continued service and commitment of the director to the company.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects the vesting of existing equity compensation.
Key Dates
| Date | Description |
|---|---|
| 03/23/2023 | Start date of annual vesting of RSUs in three equal installments |
| 03/28/2025 | Date of transaction: vesting of 1,149 restricted share units |
Keywords
HealthStream, Director, Stock Transaction, Restricted Share Units, RSU, Common Stock, Beneficial Ownership, Form 4, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.